医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

OMRON Healthcare Selects Intertrust Platform to Comprehensively Manage Globally Deployed System Operations

2023年02月09日 PM11:00
このエントリーをはてなブックマークに追加


 

TOKYO & SAN FRANCISCO

Intertrust, the world’s leading trusted distributed computing and rights management provider, today announced that OMRON Healthcare Co., Ltd. selected Intertrust’s cutting edge trusted data management technology Intertrust Platform to securely govern system log data worldwide for OMRON’s OMRON connect healthcare data mobile app service, used by approximately 4.6 million users worldwide.

OMRON connect provides OMRON Healthcare’s personal medical device customers with a convenient mobile app to help manage the health data collected from their devices. Access status of the supporting systems is output as system logs, which are distributed to operating regions around the world for security reasons. Leveraging the use of Intertrust Platform™ to centralize cross-management of output system log data, OMRON Healthcare is now able to virtually aggregate and analyze large volumes of distributed output log data without the additional expense and risk of moving the data to a centralized data repository. The company will also use Intertrust Platform to combine the virtually aggregated log data with other types of data sources such as databases and visualize the combined data while securely governing access to it. With the integration, OMRON Healthcare will gain trusted, reliable, customer-focused and comprehensive real-time monitoring and analyses for their worldwide system operations.

“Visualizing our worldwide IT operations in a single digital view is an important strategy for us to provide efficient, centralized, and high-quality operations while maintaining secure distributed operations. Using Intertrust Platform™ is a reliable way to achieve security and efficiency for our log storage,” said Naoto Ashida, OMRON Healthcare’s General Manager.

“We are honored to enable OMRON Healthcare to manage sensitive, distributed data sets across their organization,” said Yutaka Nagao, Intertrust’s Senior Vice President, Technology Initiatives & Managing Director Intertrust Japan.

Major corporations around the world use Intertrust Platform for device and data interoperability. Intertrust’s flagship product provides enterprises with secure and seamless interoperability for distributed data services that allows enterprises with diverse data sets held in locations such as cloud, data warehouses, and databases, to operate as one system. In addition, the technology allows for code-once, run anywhere capabilities, compliance with regulatory requirements, and faster time to AI. Intertrust Platform’s ability to provide consistent scalable security for IoT and data operations is unique and essential on today’s Internet.

About Intertrust

Intertrust provides trusted computing products and services to leading global corporations–from mobile, consumer electronics and IoT manufacturers, to service providers and enterprise software platform companies. These products include the world’s leading digital rights management (DRM) and technologies to enable private data exchanges for various verticals, including energy, entertainment, retail/marketing, automotive, fintech, and IoT. Founded in 1990, Intertrust is headquartered in Silicon Valley with regional offices in London, Tokyo, Mumbai, Bangalore, Beijing, Seoul, and Tallinn. The company has a legacy of invention, and its fundamental contributions in the areas of computer security and digital trust are globally recognised. Intertrust holds hundreds of patents that are key to Internet security, trust, and privacy management components of operating systems, trusted mobile code and networked operating environments, web services, and cloud computing. Additional information is available at intertrust.com, or follow us on Twitter or LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230209005129/en/

CONTACT

Jordan Slade

MSR Communications

jordan@msrcommunications.com

+1 757-876-5809

同じカテゴリーの記事 

  • Takeda Presents Late-Breaking Data from Phase 2b Study of Mezagitamab, Demonstrating Potential to Transform Treatment of Primary Immune Thrombocytopenia
  • エスリのテクノロジーをALS治療開発研究所が治験場所検索に採用
  • ALS Therapy Development Institute利用Esri技术绘制临床试验地图
  • Takeda Receives Approval from European Commission for FRUZAQLA in Previously Treated Metastatic Colorectal Cancer
  • コルマーBNH、ヘモヒムの二重機能で国際競争力を強化